Clinical Trial Update: CMV Antiviral Prevention Strategies in D+R-Liver Transplants ("CAPSIL") [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on CMV antiviral prevention strategies in cytomegalovirus infection; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Cytomegalovirus Infection | Phase 4 | Status: COMPLETED | Results posted: 2019-07-02